$DTIL·8-K

PRECISION BIOSCIENCES INC · Jun 16, 4:03 PM ET

Compare

PRECISION BIOSCIENCES INC 8-K

Research Summary

AI-generated summary

Updated

Precision BioSciences, Inc. Amends Loan Agreement, Extends Term Loan Maturity

What Happened
Precision BioSciences, Inc. announced on an 8-K filed June 16, 2026 that it entered into a First Amendment to its Amended and Restated Loan and Security Agreement with Banc of California. The amendment, dated June 10, 2026, extends the maturity date of the Company’s Term Loan from June 30, 2027 to December 31, 2029. The original Loan and Security Agreement was dated July 31, 2024.

Key Details

  • First Amendment signed June 10, 2026; 8-K filed June 16, 2026.
  • Lender: Banc of California.
  • Term loan maturity extended from June 30, 2027 to December 31, 2029.
  • The amendment is filed as Exhibit 10.1 to the 8-K; the filing also references Item 2.03 (Creation of a Direct Financial Obligation).

Why It Matters
Extending the term loan’s maturity pushes the Company’s debt repayment deadline out by roughly 2.5 years, which can reduce near-term refinancing pressure and affect Precision BioSciences’ liquidity planning. Investors should note the amendment changes the timing of the company’s outstanding debt obligations but the 8-K does not disclose other revised financial terms here; the full amendment is available as an exhibit to the filing for complete details.

Loading document...